(Q41366414)

30 September 2017

title

Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent (English)

1 reference

30 September 2017

0 references

1 reference

N. H. Riordan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7609676

15 June 2024

H. D. Riordan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7609676

15 June 2024

X. Meng

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7609676

15 June 2024

Y. Li

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7609676

15 June 2024

J. A. Jackson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7609676

15 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7609676

15 June 2024

publication date

1 March 1995

1 reference

full work available at URL

30 September 2017

https://api.elsevier.com/content/article/PII:030698779590137X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

https://api.elsevier.com/content/article/PII:030698779590137X?httpAccept=text/plain

15 June 2024

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

15 June 2024

1 reference

30 September 2017

volume

44

1 reference

30 September 2017

issue

3

1 reference

30 September 2017

page(s)

207-213

1 reference

Evolution of chemotherapy

30 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Cancer chemotherapeutic and biologic agents

15 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

15 June 2024

Cancer statistics, 1994.

3

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Synergistic Killing of Ehrlich Ascites Carcinoma Cells by Ascorbate and 3-Amino-1,2,4,-triazole

15 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Vitamin C preferential toxicity for malignant melanoma cells

15 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. I. Synergism of combined vitamin C and K3 action

15 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Characterization of a new malignant human T-cell line (PFI-285) sensitive to ascorbic acid

15 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Growth suppression of human leukemic cells in vitro by L-ascorbic acid

15 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Antitumor potency of ascorbic, dehydroascorbic or 2,3-diketogulonic acid and their action on deoxyribonucleic acid

15 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Effects of tetraacetyl-bis-dehydroascorbic acid, a derivative of ascorbic acid, on Ehrlich cells and HeLa cells (human carcinoma cells)

15 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Toxicity, radiation sensitivity modification, and metabolic effects of dehydroascorbate and ascorbate in mammalian cells,

15 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Vitamin C inhibits DNA, RNA and protein synthesis in epithelial neoplastic cells

15 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Inhibition of transplantable melanoma tumor development in mice by prophylactic administration of Ca-ascorbate

15 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

In vivo antineoplastic activity of ascorbic acid for human mammary tumor

15 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Ascorbic acid and cancer: a review

15 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Ascorbic Acid: Biologic Functions and Relation to Cancer

15 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Effect of vitamin C supplements on cell-mediated immunity in old people

15 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

The treatment of poliomyelitis and other virus diseases with vitamin C

15 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Massive doses of vitamin C and the virus diseases

15 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Ascorbic acid as a chemotherapeutic agent

15 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

The multifactorial role of vitamin C in health and disease

15 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Vitamin C and the immune response

15 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Protocol for the use of vitamin C in the treatment of cancer

15 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

The orthomolecular treatment of cancer. I. The role of ascorbic acid in host resistance

15 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer

15 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

The orthomolecular treatment of cancer. III. Reticulum cell sarcoma: double complete regression induced by high-dose ascorbic acid therapy

15 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer

15 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Innovation vs. quality control: an 'unpublishable' clinical trial of supplemental ascorbate in incurable cancer

15 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Supplemental ascorbate in the supportive treatment of cancer: Reevaluation of prolongation of survival times in terminal human cancer

15 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Ascorbic acid and cancer: a review

15 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Vitamin C therapy of advanced cancer

15 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Prolongation of survival times of terminal cancer patients by administration of large doses of ascorbate

15 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial

15 June 2024

47

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison

15 June 2024

48

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Acute Reactions to Mega Ascorbic Acid Therapy in Malignant Disease

15 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

An endotoxin-induced serum factor that causes necrosis of tumors

15 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Vitamin C: Its Molecular Biology and Medical Potential

15 June 2024

54

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Vitamin C: the nontoxic, nonrate-limited, antioxidant free radical scavenger

15 June 2024

55

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

Serum and red blood cell magnesium, copper, and zinc content in G6PD deficiency

15 June 2024

57

1 reference

https://api.crossref.org/works/10.1016/0306-9877(95)90137-X

15 June 2024

Identifiers

1 reference

release_dssvilzhffcnncyxipjdsfopg4

30 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dssvilzhffcnncyxipjdsfopg4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference